Narrative review examines immunotherapy options for anti-GQ1b antibody syndromes including BBE and Miller Fisher syndrome.
A Rare Brainstem Condition Has a New Diagnostic Map
This narrative review evaluates the role of immunotherapy in patients with anti-GQ1b antibody syndromes, including Bickerstaff Brainstem Enc…
A new model groups rare brain disorders causing double vision and balance problems into one clear spectrum to help doctors diagnose confusin…
Efgartigimod showed higher independent walking at week 4 and running at week 12 versus IVIG in GBS patients unable to walk.
A Newer Drug Outperformed the Standard Treatment for a Paralyzing Nerve Disease
This single-center retrospective study evaluated efgartigimod versus intravenous immunoglobulin (IVIG) in 34 Guillain-Barré syndrome patient…
A newer drug helped 100% of paralyzed Guillain-Barré patients walk again in four weeks, outperforming the standard treatment in a recent stu…